Full Text View
Tabular View
No Study Results Posted
Related Studies
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
This study has been terminated.
( European reports of liver toxicity from kava meant that the study had to stop )
Study NCT00083980   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)

First Received on June 4, 2004.   Last Updated on October 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anxiety Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
Venlafaxine ER
Sugar pill
Kava
Additional drug interventions recognized in this trial
Venlafaxine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Center for Complementary and Alternative Medicine (NCCAM)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services